ID   DCLK2_HUMAN             Reviewed;         766 AA.
AC   Q8N568; C9J5Q9; Q59GC8; Q8N399;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   12-OCT-2022, entry version 168.
DE   RecName: Full=Serine/threonine-protein kinase DCLK2;
DE            EC=2.7.11.1;
DE   AltName: Full=CaMK-like CREB regulatory kinase 2;
DE            Short=CL2;
DE            Short=CLICK-II;
DE            Short=CLICK2;
DE   AltName: Full=Doublecortin domain-containing protein 3B;
DE   AltName: Full=Doublecortin-like and CAM kinase-like 2;
DE   AltName: Full=Doublecortin-like kinase 2;
GN   Name=DCLK2; Synonyms=DCAMKL2, DCDC3B, DCK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 68-766 (ISOFORM 3).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   GENE FAMILY.
RX   PubMed=16869982; DOI=10.1186/1471-2164-7-188;
RA   Reiner O., Coquelle F.M., Peter B., Levy T., Kaplan A., Sapir T., Orr I.,
RA   Barkai N., Eichele G., Bergmann S.;
RT   "The evolving doublecortin (DCX) superfamily.";
RL   BMC Genomics 7:188-188(2006).
RN   [5]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=18075264; DOI=10.1159/000109861;
RA   Tuy F.P.D., Saillour Y., Kappeler C., Chelly J., Francis F.;
RT   "Alternative transcripts of Dclk1 and Dclk2 and their expression in
RT   doublecortin knockout mice.";
RL   Dev. Neurosci. 30:171-186(2008).
RN   [6]
RP   REVIEW, AND GENE FAMILY.
RX   PubMed=20236041; DOI=10.2174/187152410790780118;
RA   Dijkmans T.F., van Hooijdonk L.W.A., Fitzsimons C.P., Vreugdenhil E.;
RT   "The doublecortin gene family and disorders of neuronal structure.";
RL   Cent. Nerv. Syst. Agents Med. Chem. 10:32-46(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-61 AND SER-362, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-119; HIS-372 AND VAL-583.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [9]
RP   VARIANT MET-212.
RX   PubMed=25512093; DOI=10.1002/humu.22744;
RA   Peeters K., Bervoets S., Chamova T., Litvinenko I., De Vriendt E.,
RA   Bichev S., Kancheva D., Mitev V., Kennerson M., Timmerman V., De Jonghe P.,
RA   Tournev I., MacMillan J., Jordanova A.;
RT   "Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical
RT   spectrum of dyneinopathies.";
RL   Hum. Mutat. 36:287-291(2015).
CC   -!- FUNCTION: Protein kinase with a significantly reduced C(a2+)/CAM
CC       affinity and dependence compared to other members of the CaMK family.
CC       May play a role in the down-regulation of CRE-dependent gene activation
CC       probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the
CC       resulting retention of TORC2 in the cytoplasm (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Binds to and stabilizes microtubules. Interacts with
CC       MAPK8IP1/JIP-1, MAPK8IP2/JIP-2, MAPK9/JNK2, PPP1R9B/NEURABIN-2 and
CC       actin. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8N568; Q96M94: KLHL15; NbExp=3; IntAct=EBI-2930406, EBI-2510129;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Note=Colocalizes with
CC       microtubules. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N568-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N568-2; Sequence=VSP_012794;
CC       Name=3;
CC         IsoId=Q8N568-3; Sequence=VSP_012793;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, heart and eyes.
CC       {ECO:0000269|PubMed:18075264}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain, and, to a lower extent,
CC       in fetal kidney. {ECO:0000269|PubMed:18075264}.
CC   -!- DOMAIN: The doublecortin domains are involved in the colocalization
CC       with microtubules. {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: By homology to mouse isoform 2.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92418.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB209181; BAD92418.1; ALT_INIT; mRNA.
DR   EMBL; AC093748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC118064; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL834498; CAD39156.1; -; mRNA.
DR   CCDS; CCDS34076.1; -. [Q8N568-1]
DR   CCDS; CCDS47142.2; -. [Q8N568-3]
DR   RefSeq; NP_001035350.2; NM_001040260.3. [Q8N568-1]
DR   RefSeq; NP_001035351.4; NM_001040261.4. [Q8N568-3]
DR   RefSeq; XP_005262843.1; XM_005262786.2. [Q8N568-2]
DR   AlphaFoldDB; Q8N568; -.
DR   SMR; Q8N568; -.
DR   BioGRID; 127929; 10.
DR   IntAct; Q8N568; 23.
DR   STRING; 9606.ENSP00000303887; -.
DR   BindingDB; Q8N568; -.
DR   ChEMBL; CHEMBL5519; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q8N568; -.
DR   GuidetoPHARMACOLOGY; 2006; -.
DR   iPTMnet; Q8N568; -.
DR   PhosphoSitePlus; Q8N568; -.
DR   BioMuta; DCLK2; -.
DR   DMDM; 296439470; -.
DR   EPD; Q8N568; -.
DR   jPOST; Q8N568; -.
DR   MassIVE; Q8N568; -.
DR   MaxQB; Q8N568; -.
DR   PaxDb; Q8N568; -.
DR   PeptideAtlas; Q8N568; -.
DR   PRIDE; Q8N568; -.
DR   ProteomicsDB; 72008; -. [Q8N568-1]
DR   ProteomicsDB; 72009; -. [Q8N568-2]
DR   ProteomicsDB; 72010; -. [Q8N568-3]
DR   Antibodypedia; 16499; 181 antibodies from 33 providers.
DR   DNASU; 166614; -.
DR   Ensembl; ENST00000296550.12; ENSP00000296550.7; ENSG00000170390.16. [Q8N568-1]
DR   Ensembl; ENST00000302176.8; ENSP00000303887.8; ENSG00000170390.16. [Q8N568-3]
DR   Ensembl; ENST00000506325.5; ENSP00000427235.1; ENSG00000170390.16. [Q8N568-2]
DR   GeneID; 166614; -.
DR   KEGG; hsa:166614; -.
DR   MANE-Select; ENST00000296550.12; ENSP00000296550.7; NM_001040260.4; NP_001035350.2.
DR   UCSC; uc003ilm.5; human. [Q8N568-1]
DR   CTD; 166614; -.
DR   DisGeNET; 166614; -.
DR   GeneCards; DCLK2; -.
DR   HGNC; HGNC:19002; DCLK2.
DR   HPA; ENSG00000170390; Tissue enhanced (brain).
DR   MIM; 613166; gene.
DR   neXtProt; NX_Q8N568; -.
DR   OpenTargets; ENSG00000170390; -.
DR   PharmGKB; PA162383366; -.
DR   VEuPathDB; HostDB:ENSG00000170390; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000154895; -.
DR   InParanoid; Q8N568; -.
DR   OMA; LMTECKV; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; Q8N568; -.
DR   TreeFam; TF318770; -.
DR   PathwayCommons; Q8N568; -.
DR   SignaLink; Q8N568; -.
DR   BioGRID-ORCS; 166614; 13 hits in 1104 CRISPR screens.
DR   ChiTaRS; DCLK2; human.
DR   GenomeRNAi; 166614; -.
DR   Pharos; Q8N568; Tchem.
DR   PRO; PR:Q8N568; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q8N568; protein.
DR   Bgee; ENSG00000170390; Expressed in oocyte and 120 other tissues.
DR   ExpressionAtlas; Q8N568; baseline and differential.
DR   Genevisible; Q8N568; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IEA:Ensembl.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0021860; P:pyramidal neuron development; IEA:Ensembl.
DR   Gene3D; 3.10.20.230; -; 2.
DR   InterPro; IPR003533; Doublecortin_dom.
DR   InterPro; IPR036572; Doublecortin_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF03607; DCX; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00537; DCX; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF89837; SSF89837; 2.
DR   PROSITE; PS50309; DC; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Cytoskeleton; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..766
FT                   /note="Serine/threonine-protein kinase DCLK2"
FT                   /id="PRO_0000085922"
FT   DOMAIN          72..158
FT                   /note="Doublecortin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          197..280
FT                   /note="Doublecortin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          394..651
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          707..766
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        7..23
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        27..42
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        300..368
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        716..753
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        515
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         400..408
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         423
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         61
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5MPA9"
FT   MOD_RES         666
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5MPA9"
FT   VAR_SEQ         321
FT                   /note="V -> VKRGGHYSSAYSTAKSPV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012793"
FT   VAR_SEQ         353
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_012794"
FT   VARIANT         119
FT                   /note="G -> C (in dbSNP:rs56327537)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040441"
FT   VARIANT         212
FT                   /note="V -> M (found in a patient with hereditary motor and
FT                   sensory neuropathy; unknown pathological significance;
FT                   dbSNP:rs759398144)"
FT                   /evidence="ECO:0000269|PubMed:25512093"
FT                   /id="VAR_073158"
FT   VARIANT         372
FT                   /note="R -> H (in dbSNP:rs34386880)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040442"
FT   VARIANT         583
FT                   /note="I -> V (in dbSNP:rs35745104)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040443"
FT   CONFLICT        694
FT                   /note="A -> V (in Ref. 3; CAD39156)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        748
FT                   /note="P -> C (in Ref. 1; BAD92418 and 3; CAD39156)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   766 AA;  83606 MW;  024F3223874AE83C CRC64;
     MASTRSIELE HFEERDKRPR PGSRRGAPSS SGGSSSSGPK GNGLIPSPAH SAHCSFYRTR
     TLQALSSEKK AKKARFYRNG DRYFKGLVFA ISSDRFRSFD ALLIELTRSL SDNVNLPQGV
     RTIYTIDGSR KVTSLDELLE GESYVCASNE PFRKVDYTKN INPNWSVNIK GGTSRALAAA
     SSVKSEVKES KDFIKPKLVT VIRSGVKPRK AVRILLNKKT AHSFEQVLTD ITEAIKLDSG
     VVKRLCTLDG KQVTCLQDFF GDDDVFIACG PEKFRYAQDD FVLDHSECRV LKSSYSRSSA
     VKYSGSKSPG PSRRSKSPAS VNGTPSSQLS TPKSTKSSSS SPTSPGSFRG LKQISAHGRS
     SSNVNGGPEL DRCISPEGVN GNRCSESSTL LEKYKIGKVI GDGNFAVVKE CIDRSTGKEF
     ALKIIDKAKC CGKEHLIENE VSILRRVKHP NIIMLVEEME TATELFLVME LVKGGDLFDA
     ITSSTKYTER DGSAMVYNLA NALRYLHGLS IVHRDIKPEN LLVCEYPDGT KSLKLGDFGL
     ATVVEGPLYT VCGTPTYVAP EIIAETGYGL KVDIWAAGVI TYILLCGFPP FRSENNLQED
     LFDQILAGKL EFPAPYWDNI TDSAKELISQ MLQVNVEARC TAGQILSHPW VSDDASQENN
     MQAEVTGKLK QHFNNALPKQ NSTTTGVSVI MNTALDKEGQ IFCSKHCQDS GRPGMEPISP
     VPPSVEEIPV PGEAVPAPTP PESPTPHPPP AAPGGERAGT WRRHRD
//
